Northwestern Mutual Wealth Management Co. Has $123.35 Million Position in Globe Life Inc. $GL

Northwestern Mutual Wealth Management Co. lifted its stake in shares of Globe Life Inc. (NYSE:GL) by 34,786.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 881,919 shares of the company’s stock after acquiring an additional 879,391 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Globe Life were worth $123,345,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of GL. AQR Capital Management LLC lifted its position in shares of Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after acquiring an additional 696,548 shares during the period. Balyasny Asset Management L.P. acquired a new position in shares of Globe Life during the 3rd quarter valued at $80,925,000. Westfield Capital Management Co. LP acquired a new position in shares of Globe Life during the 3rd quarter valued at $61,569,000. Teachers Retirement System of The State of Kentucky lifted its position in shares of Globe Life by 2,617.6% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 182,215 shares of the company’s stock valued at $25,485,000 after acquiring an additional 175,510 shares during the period. Finally, Arbejdsmarkedets Tillaegspension acquired a new position in shares of Globe Life during the 4th quarter valued at $24,442,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Insider Buying and Selling

In related news, CEO James Matthew Darden sold 4,663 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total value of $717,542.44. Following the transaction, the chief executive officer owned 58,451 shares in the company, valued at approximately $8,994,439.88. This represents a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 107,147 shares of company stock worth $16,086,366 in the last three months. Insiders own 2.11% of the company’s stock.

Globe Life Price Performance

Shares of NYSE:GL opened at $155.05 on Friday. The company’s 50-day moving average is $145.97 and its 200 day moving average is $141.13. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market capitalization of $12.04 billion, a P/E ratio of 10.72 and a beta of 0.50. Globe Life Inc. has a fifty-two week low of $116.73 and a fifty-two week high of $156.69.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The company had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.Globe Life’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm posted $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities research analysts forecast that Globe Life Inc. will post 15.56 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is 9.13%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Evercore set a $157.00 target price on shares of Globe Life in a research report on Wednesday, February 18th. Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Piper Sandler upgraded shares of Globe Life to a “strong-buy” rating in a research note on Thursday, April 2nd. Keefe, Bruyette & Woods restated a “moderate buy” rating and set a $168.00 price target on shares of Globe Life in a research note on Thursday, March 26th. Finally, Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $172.67.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.